The burden and cost of cancer

Annals of Oncology

Volumn 18, Issue SUPPL. 3, 2007, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANADA; CANCER INCIDENCE; CANCER MORTALITY; COST OF ILLNESS; DRUG COST; EUROPEAN UNION; HEALTH CARE COST; HUMAN; NEOPLASM; PRIORITY JOURNAL; UNITED STATES;

EID: 44149088519     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm097     Document Type: Article

References (28)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24(14): 2137-2150.
2. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16(3): 481-488.
3. International Agency for Research on Cancer. CANCERMondial. 2005 http://www-dep.iarc.fr/.
4. World Health Organization. Priority medicines for Europe and the world. WHO/EDM/PAR/2004.7.2004; http://whqlibdoc.who.int(hq/2004/ WHO_EDM_PAR_2004.7.pdf.
5. WHO Death and DALY estimates for 2002 by cause for WHO Member States. http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls.
6. Economic Burden of Illness in Canada, 1998. Health Canada 2002; www.phac-aspc.gc.ca/publicat/ebic-femc98/pdf/ebic1998.pdf.
7. Disease-specific Estimates of Direct and Indirect Costs of Illness and NIH Support. National Institutes of Health 2000.
8. Brown M, Lipscomb J, Snyder C. The burden of illness of cancer: Economic cost and quality of life. Annu Rev Public Health 2001; 22: 91-113.
9. Jönsson B, Karlsson G. Economic evaluation of cancer treatments. In Domellof L (ed): Drug Delivery in Cancer Treatment III. Berlin-Heidelberg, Germany: Springer-Verlag 1990.
10. Gesundheit - Krankheitskosten 2002, Wiesbaden, Germany: Statistisches Bundesamt 2004.
11. Santé-Solidarités. Publications de la DREES. 2002 http://www.sante.gouv.fr/htm/publication/.
12. National Institute for Public Health and the Environment (RIVM). Cost of illness in the Netherlands. 2004; http://www.rivm.nl/kostenvanziekten/ site_en/index.htm.
13. Meerding WJ et al. Demographic and epidemiological determinants of healthcare costs in Netherlands: Cost of illness study. BMJ 1998; 317(7151): 111-115.
14. Koopmanschap MA et al. Current and future costs of cancer. Eur J Cancer 1994; 30A(1): 60-65.
15. Polder JJ et al. A cross-national perspective on cost of illness: A comparison of studies from The Netherlands, Australia, Canada, Germany, United Kingdom, Sweden. Eur J Health Econ 2005; 6(3): 223-232.
16. Bosanquet N, Sikora K. The economics of cancer care in the UK. Lancet Oncol 2004; 5(9): 568-574.
17. Bosanquet N, Attridge J, Sikora K. Can the new EU members catch up in cancer care? EuroHealth 2005; 11(1).
18. Cancer Trends Progress Report - 2005 Update. Bethesda, MD: National Cancer Institute, NIH, DHHS 2005.
19. Mathers C et al. Health system costs of cancer in Australia 1993-94. Canberra, Australia: The Australian Institute of Health and Welfare and the National Cancer Control Initiative of the Commonwealth Department of Health and Family Services 1998.
20. Cancer Statistics in Japan '05, National medical care expenditure trends in Japan. (1977-2002) www.ncc.go.jp/en/statistics/2005/index.html.
21. Center for Medical Technology Assessment. Cost of illness in the county of Östergötland in 2002. CMT report.
22. Ragnarson Tennvall G, Karlsson G. Cancer treatment in Sweden - costs of drugs, inpatient and outpabent care from 1985 to 1996 and cost effectiveness of new drugs. Acta Oncol 1998; 37(5): 447-453.
23. Organisation for Economic Co-operation and Development. OECD Health Data 2005: Stabstics and Indicators for 30 Countries. 2005; http://www.oecd.org/document/ 3002340,en_2469201185_12968734_1_1_1_1,00.html.
24. Swedish Council on Technology Assessment in Health Care. SBU Yellow Report. Chemotherapy for cancer. Report no. 155/2.2001; http://www.sbu.se/www/index.asp.
25. Lopez-Bastida J, SerranoAguilar P, Duque-Gonzalez B. Los costes socieeconomicos de las enfermedades cardiovasculares y del cancer en las Islas Canarias en 1998. Gac Sanit 2003; 17(3): 210-217.
26. Cancer facts and figures. American Cancer Society 2003.
27. Chang S et al. Estimating the cost of cancer: Results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol 2004; 22(17): 3524-3530.
28. Cancerfondsraporten 2006. Swedish Cancer Society: www.cancerfonden.se.